HomeLatest ThreadsGreatest ThreadsForums & GroupsMy SubscriptionsMy Posts
DU Home » Latest Threads » mnhtnbb » Journal
Page: 1

mnhtnbb

Profile Information

Gender: Female
Hometown: NYC
Home country: USA
Current location: Durham, NC
Member since: Sat May 7, 2005, 11:13 PM
Number of posts: 29,416

Journal Archives

Duke University leading national study to assess effectiveness of Ivermectin

as a treatment for COVID-19.

This was the above the fold front page article in the Raleigh News & Observer this morning.

Doctors at Duke University are leading a national study to test whether three drugs will effectively treat COVID-19, including one that has generated controversy for more than a year. Ivermectinís potential to treat COVID-19 has been both celebrated and ridiculed. Some consider it a miracle drug that makes vaccination against the coronavirus unnecessary. But most in the medical establishment, including government regulators, say thereís not enough proof that it works and warn that self-medicating with ivermectin can make people sick in other ways. The Duke study, launched last summer, is the kind of comprehensive assessment of ivermectinís ability to combat COVID-19 that has been missing up to now, said Dr. Adrian Hernandez, one of the studyís leaders.

Ivermectin is one of three drugs that Duke is testing under ACTIV-6, one of a series of studies of potential COVID-19 treatments and vaccines launched by the National Institutes of Health.

The two other drugs being tested in the ACTIV-6 study are fluvoxamine, used to treat obsessive-compulsive disorder and depression, and fluticasone furoate, an inhaler medicine prescribed for asthma and chronic obstructive pulmonary disease or COPD.

Researchers are looking for evidence that the drugs either shorten the time people feel sick or prevent them from getting worse and needing to be hospitalized.

For information about the ACTIV-6 study, go to activ6study.org/.



Read more at: https://www.newsobserver.com/news/coronavirus/article257483164.html#storylink=cpy

Go to Page: 1